Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Carcinoma, Basal Cell, Skin Neoplasms

Squamous Intraepithelial Lesions, HIV Infections

Uterine Cervical Dysplasia

Keratosis, Actinic

Glioblastoma

Squamous Cell Carcinoma of Head and Neck

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

Bone Neoplasms, Sarcoma

Hutchinson's Melanotic Freckle

Uterine Cervical Dysplasia

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

Carcinoma, Basal Cell

Leukemia, Lymphocytic, Chronic, B-Cell

Astrocytoma, Glioblastoma, Glioma

Carcinoma, Basal Cell

Carcinoma, Basal Cell

Keratosis, Actinic

Condylomata Acuminata

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Breast Neoplasms

Patient Satisfaction

Uterine Cervical Neoplasms

Keratosis, Actinic

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

Keratosis, Actinic

Keratosis, Actinic

Glioma, Lymphoma, Follicular

Paget Disease, Extramammary

Keratosis, Actinic

Breast Neoplasms, Stomach Neoplasms

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Uterine Cervical Dysplasia

Vulvar Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Uterine Cervical Dysplasia

Neurofibromatosis 1

Keratosis, Actinic

Clinical Trials

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

SONIB

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

ANCHOR

Dendritic Cell Vaccine for Children and Adults With Sarcoma

RADICAL

Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Aldara for the Treatment of Large and/or Multiple sBCC

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

LEIDA

LEIDA 2

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases

PITVIN

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

HER2

DRibble

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

MEL53

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses